Vittorio Sebastiano

The technology at the foundation of Turn’s ERA™ platform was developed and patented in Vittorio’s Stanford University lab. An expert in stem cell biology and epigenetic reprogramming, he has worked in some of the world’s most prestigious academic institutions and is on the faculty of Stanford School of Medicine. He received his bachelor’s degree and doctorate from the University of Pavia and completed post-doctoral work at the Max Planck Institute for Molecular Biomedicine in Germany and Stanford.